A study led by Columbia obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.
Researchers at Columbia University Vagelos College of Physicians and Surgeons are leading the first U.S. trial of an experimental vaccine designed to treat an opioid use disorder.
A new preclinical study provides the first direct evidence that loss of a placental hormone during pregnancy alters long-term brain development, causing autism-like behaviors in male offspring.
Keith Diaz, May Hua, Jennifer Woo Baidal, and Hanrui Zhang will receive funding over the next three years to support their clinical and translational research.
A fat ‘shield’ that protects natural killer cells from self-destruction also allows some cancer cells to evade destruction by the immune system, researchers at Columbia University have found.
Twelve Columbia research teams have been awarded Columbia Life Science Accelerator pilot grants to develop technologies that aim to change the way patients are treated or diagnosed.